Morgan Stanley Mesoblast LTD Transaction History

Morgan Stanley

  • $1.27 Trillion
  • Q2 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 16, 2024
BUY
$1.0 - $1.39 $310,444 - $431,517
310,444 New
310,444 $341,000
Q4 2023

Feb 13, 2024
BUY
$1.0 - $1.39 $220,606 - $306,642
220,606 Added 245.56%
310,444 $341,000
Q3 2023

Nov 15, 2023
SELL
$1.22 - $4.83 $152,309 - $602,996
-124,844 Reduced 58.15%
89,838 $110,000
Q2 2023

Aug 14, 2023
BUY
$2.95 - $4.44 $102,167 - $153,770
34,633 Added 19.24%
214,682 $839,000
Q1 2023

May 15, 2023
SELL
$2.94 - $4.18 $26,462 - $37,624
-9,001 Reduced 4.76%
180,049 $592,000
Q4 2022

Feb 14, 2023
SELL
$2.73 - $3.7 $22,323 - $30,254
-8,177 Reduced 4.15%
189,050 $550,000
Q3 2022

Nov 14, 2022
BUY
$0.48 - $3.48 $27,087 - $196,383
56,432 Added 40.08%
197,227 $501,000
Q2 2022

Oct 27, 2022
BUY
$2.22 - $4.54 $86,031 - $175,938
38,753 Added 37.98%
140,795 $312,000
Q2 2022

Aug 15, 2022
BUY
$2.22 - $4.54 $86,031 - $175,938
38,753 Added 37.98%
140,795 $312,000
Q1 2022

Oct 27, 2022
SELL
$3.58 - $4.98 $138,735 - $192,989
-38,753 Reduced 27.52%
102,042 $431,000
Q1 2022

May 13, 2022
SELL
$3.58 - $4.98 $344,968 - $479,872
-96,360 Reduced 48.57%
102,042 $431,000
Q4 2021

Feb 14, 2022
SELL
$4.17 - $7.09 $63,680 - $108,271
-15,271 Reduced 7.15%
198,402 $952,000
Q3 2021

Nov 15, 2021
BUY
$5.87 - $7.85 $1.25 Million - $1.68 Million
213,673 New
213,673 $1.28 Million

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.2B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email